About Us 


In Brazil, we can do cutting edge Science! When research results in Science and Science turns into a technology that improves the health and well-being of Brazilian citizens, we must give all the credits to our public universities.

NEOGENYS is precisely like that! Resulted from three Research fellows that graduated in the University of São Paulo at Ribeirão Preto, with expertise and training from well renowned worldwide institutes: Indiana University School of Medicine-EUA, MD Anderson Cancer Center-EUA, University of Zurich-Suiça, European Research Institute for the Biology of Ageing-Netherlands and Harvard University. These fellows joined and created the idea of transforming basic molecular research into a molecular diagnosis for oncology. Here, the knowledge about tumor biology, molecular diagnosis, and bioinformatics is overwhelmed.

Thus, baptized as NEOGENYS, our startup aims to develop research and raise solutions in the field of Molecular Diagnosis in Oncology, specifically related to risk stratification factors associated with specific gene signatures. Using our diagnosis, we believe that doctors will have a higher precision during rapid-clinical decision making regarding treatment protocol for patients.